Value of Preoperative Use of Statins as a Protective Factor for Severe Graft Dysfunction After Lung Transplantation: A Multicenter Propensity Score Analysis

Arch Bronconeumol. 2021 Nov;57(11):720-722. doi: 10.1016/j.arbr.2021.04.015.
No abstract available

Publication types

  • Case Reports
  • Multicenter Study

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Lung Transplantation* / adverse effects
  • Primary Graft Dysfunction*
  • Propensity Score
  • Protective Factors
  • Retrospective Studies

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors